Cell Therapy Manufacturing Market
Cell Therapy Manufacturing Market
The global cell therapy manufacturing market is estimated to grow from USD 6.12 billion in 2025 at 16% CAGR (2025-2034) to reach an estimated USD 23.27 billion by 2034.
Report ID: 10049
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 5.27 Bn
Forecast Year,
USD USD 23.27 Bn
CAGR, 2025 -
16%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cell Therapy Manufacturing Market Size Analysis
Cell Therapy Manufacturing Market Size By Therapy 2024 to 2034 (USD )
| Therapy | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Autologous Cell Therapy | 2898.50 | 3350.03 | 3871.86 | 4474.90 | 5171.80 | 5977.15 | 6907.82 | 7983.28 | 9226.05 | 10662.13 | 12321.58 |
| Allogeneic Cell Therapy | 2371.50 | 2763.17 | 3219.46 | 3751.02 | 4370.27 | 5091.65 | 5931.99 | 6910.90 | 8051.20 | 9379.47 | 10926.68 |
Cell Therapy Manufacturing Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Somatic Cell Technology | 1054.00 | 1225.70 | 1425.35 | 1657.52 | 1927.50 | 2241.43 | 2606.48 | 3030.97 | 3524.56 | 4098.51 | 4765.89 |
| 3D Technology | 790.50 | 923.09 | 1077.88 | 1258.57 | 1469.48 | 1715.66 | 2003.01 | 2338.39 | 2729.80 | 3186.62 | 3719.72 |
| Cell Immortalization Technology | 790.50 | 910.87 | 1049.51 | 1209.21 | 1393.14 | 1604.98 | 1848.93 | 2129.87 | 2453.37 | 2825.87 | 3254.76 |
| Viral Vector Technology | 948.60 | 1103.43 | 1283.53 | 1493.00 | 1736.66 | 2020.06 | 2349.68 | 2733.08 | 3179.01 | 3697.68 | 4300.93 |
| Genome Editing Technology | 1054.00 | 1228.75 | 1432.45 | 1669.86 | 1946.58 | 2269.10 | 2645.00 | 3083.09 | 3593.67 | 4188.70 | 4882.14 |
| Cell Plasticity Technology | 632.40 | 721.36 | 822.59 | 937.76 | 1068.71 | 1217.57 | 1386.70 | 1578.78 | 1796.83 | 2044.24 | 2324.83 |
Cell Therapy Manufacturing Market Size By Source 2024 to 2034 (USD )
| Source | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Induced Pluripotent Stem Cells | 1317.50 | 1534.41 | 1787.01 | 2081.16 | 2423.69 | 2822.54 | 3286.99 | 3827.80 | 4457.53 | 5190.78 | 6044.55 |
| Bone Marrow | 1317.50 | 1522.19 | 1758.65 | 2031.80 | 2347.35 | 2711.86 | 3132.91 | 3619.29 | 4181.09 | 4830.03 | 5579.58 |
| Umbilical Cord | 1054.00 | 1228.75 | 1432.45 | 1669.86 | 1946.58 | 2269.10 | 2645.00 | 3083.09 | 3593.67 | 4188.70 | 4882.14 |
| Adipose Tissues | 790.50 | 910.87 | 1049.51 | 1209.21 | 1393.14 | 1604.98 | 1848.93 | 2129.87 | 2453.37 | 2825.87 | 3254.76 |
| Neural Stem | 790.50 | 916.98 | 1063.70 | 1233.89 | 1431.31 | 1660.32 | 1925.97 | 2234.13 | 2591.59 | 3006.24 | 3487.24 |
Cell Therapy Manufacturing Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Musculoskeletal | 948.60 | 1102.88 | 1282.25 | 1490.77 | 1733.20 | 2015.04 | 2342.70 | 2723.61 | 3166.45 | 3681.26 | 4279.74 |
| Cardiovascular | 790.50 | 919.58 | 1069.72 | 1244.37 | 1447.51 | 1683.81 | 1958.66 | 2278.35 | 2650.20 | 3082.71 | 3585.77 |
| Gastrointestinal | 527.00 | 614.07 | 715.51 | 833.69 | 971.36 | 1131.75 | 1318.59 | 1536.24 | 1789.78 | 2085.13 | 2429.16 |
| Neurological | 632.40 | 736.27 | 857.19 | 997.96 | 1161.82 | 1352.57 | 1574.61 | 1833.08 | 2133.95 | 2484.16 | 2891.80 |
| Oncology | 1317.50 | 1521.43 | 1756.88 | 2028.75 | 2342.63 | 2705.03 | 3123.43 | 3606.49 | 4164.17 | 4807.99 | 5551.24 |
| Dermatology | 527.00 | 611.01 | 708.42 | 821.36 | 952.30 | 1104.12 | 1280.14 | 1484.22 | 1720.83 | 1995.16 | 2313.23 |
| Others | 527.00 | 607.96 | 701.34 | 809.03 | 933.24 | 1076.49 | 1241.68 | 1432.19 | 1651.88 | 1905.20 | 2197.31 |
Cell Therapy Manufacturing Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2108.00 | 2439.17 | 2822.34 | 3265.69 | 3778.66 | 4372.18 | 5058.88 | 5853.41 | 6772.68 | 7836.27 | 9066.82 |
| Europe | 1317.50 | 1525.24 | 1765.74 | 2044.14 | 2366.43 | 2739.53 | 3171.43 | 3671.41 | 4250.20 | 4920.21 | 5695.82 |
| Asia-Pacific | 1054.00 | 1231.81 | 1439.54 | 1682.20 | 1965.67 | 2296.78 | 2683.52 | 3135.22 | 3662.78 | 4278.88 | 4998.38 |
| Latin America | 421.60 | 489.06 | 567.30 | 658.07 | 763.37 | 885.50 | 1027.18 | 1191.53 | 1382.18 | 1603.33 | 1859.86 |
| Middle East & Africa | 368.90 | 427.92 | 496.39 | 575.81 | 667.94 | 774.82 | 898.79 | 1042.59 | 1209.41 | 1402.91 | 1627.38 |
Cell Therapy Manufacturing Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
